We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · May 20, 2021

Impact and Effectiveness of mRNA BNT162b2 Vaccine Against SARS-CoV-2 Infections and COVID-19 Following a Nationwide Vaccination Campaign in Israel

The Lancet

 

Additional Info

The Lancet
Impact and Effectiveness of mRNA BNT162b2 Vaccine Against SARS-CoV-2 Infections and COVID-19 Cases, Hospitalisations, and Deaths Following a Nationwide Vaccination Campaign in Israel: An Observational Study Using National Surveillance Data
Lancet 2021 May 15;397(10287)1819-1829, EJ Haas, FJ Angulo, JM McLaughlin, E Anis, SR Singer, F Khan, N Brooks, M Smaja, G Mircus, K Pan, J Southern, DL Swerdlow, L Jodar, Y Levy, S Alroy-Preis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading